Aslam Abbasi Akhtar, Samuel Sances, Robert Barrett, Joshua J Breunig
{"title":"类器官和片上器官系统:神经和胃肠疾病建模的新范例。","authors":"Aslam Abbasi Akhtar, Samuel Sances, Robert Barrett, Joshua J Breunig","doi":"10.1007/s40778-017-0080-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>The modeling of biological processes <i>in vitro</i> provides an important tool to better understand mechanisms of development and disease, allowing for the rapid testing of therapeutics. However, a critical constraint in traditional monolayer culture systems is the absence of the multicellularity, spatial organization, and overall microenvironment present <i>in vivo</i>. This limitation has resulted in numerous therapeutics showing efficacy <i>in vitro</i>, but failing in patient trials. In this review, we discuss several organoid and \"organ-on-a-chip\" systems with particular regard to the modeling of neurological diseases and gastrointestinal disorders.</p><p><strong>Recent findings: </strong>Recently, the <i>in vitro</i> generation of multicellular organ-like structures, coined organoids, has allowed the modeling of human development, tissue architecture, and disease with human-specific pathophysiology. Additionally, microfluidic \"organ-on-a-chip\" technologies add another level of physiological mimicry by allowing biological mediums to be shuttled through 3D cultures.</p><p><strong>Summary: </strong>Organoids and organ-chips are rapidly evolving <i>in vitro</i> platforms which hold great promise for the modeling of development and disease.</p>","PeriodicalId":37444,"journal":{"name":"Current Stem Cell Reports","volume":"3 2","pages":"98-111"},"PeriodicalIF":2.3000,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624725/pdf/nihms859847.pdf","citationCount":"0","resultStr":"{\"title\":\"Organoid and Organ-On-A-Chip Systems: New Paradigms for Modeling Neurological and Gastrointestinal Disease.\",\"authors\":\"Aslam Abbasi Akhtar, Samuel Sances, Robert Barrett, Joshua J Breunig\",\"doi\":\"10.1007/s40778-017-0080-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose of review: </strong>The modeling of biological processes <i>in vitro</i> provides an important tool to better understand mechanisms of development and disease, allowing for the rapid testing of therapeutics. However, a critical constraint in traditional monolayer culture systems is the absence of the multicellularity, spatial organization, and overall microenvironment present <i>in vivo</i>. This limitation has resulted in numerous therapeutics showing efficacy <i>in vitro</i>, but failing in patient trials. In this review, we discuss several organoid and \\\"organ-on-a-chip\\\" systems with particular regard to the modeling of neurological diseases and gastrointestinal disorders.</p><p><strong>Recent findings: </strong>Recently, the <i>in vitro</i> generation of multicellular organ-like structures, coined organoids, has allowed the modeling of human development, tissue architecture, and disease with human-specific pathophysiology. Additionally, microfluidic \\\"organ-on-a-chip\\\" technologies add another level of physiological mimicry by allowing biological mediums to be shuttled through 3D cultures.</p><p><strong>Summary: </strong>Organoids and organ-chips are rapidly evolving <i>in vitro</i> platforms which hold great promise for the modeling of development and disease.</p>\",\"PeriodicalId\":37444,\"journal\":{\"name\":\"Current Stem Cell Reports\",\"volume\":\"3 2\",\"pages\":\"98-111\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2017-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624725/pdf/nihms859847.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Stem Cell Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s40778-017-0080-x\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2017/4/18 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"CELL & TISSUE ENGINEERING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Stem Cell Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40778-017-0080-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/4/18 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CELL & TISSUE ENGINEERING","Score":null,"Total":0}
Organoid and Organ-On-A-Chip Systems: New Paradigms for Modeling Neurological and Gastrointestinal Disease.
Purpose of review: The modeling of biological processes in vitro provides an important tool to better understand mechanisms of development and disease, allowing for the rapid testing of therapeutics. However, a critical constraint in traditional monolayer culture systems is the absence of the multicellularity, spatial organization, and overall microenvironment present in vivo. This limitation has resulted in numerous therapeutics showing efficacy in vitro, but failing in patient trials. In this review, we discuss several organoid and "organ-on-a-chip" systems with particular regard to the modeling of neurological diseases and gastrointestinal disorders.
Recent findings: Recently, the in vitro generation of multicellular organ-like structures, coined organoids, has allowed the modeling of human development, tissue architecture, and disease with human-specific pathophysiology. Additionally, microfluidic "organ-on-a-chip" technologies add another level of physiological mimicry by allowing biological mediums to be shuttled through 3D cultures.
Summary: Organoids and organ-chips are rapidly evolving in vitro platforms which hold great promise for the modeling of development and disease.
期刊介绍:
The goal of this journal is to publish cutting-edge reviews on subjects pertinent to all aspects of stem cell research, therapy, ethics, commercialization, and policy. We aim to provide incisive, insightful, and balanced contributions from leading experts in each relevant domain that will be of immediate interest to a wide readership of clinicians, basic scientists, and translational investigators.
We accomplish this aim by appointing major authorities to serve as Section Editors in key subject areas across the discipline. Section Editors select topics to be reviewed by leading experts who emphasize recent developments and highlight important papers published over the past year on their topics, in a crisp and readable format. We also provide commentaries from well-known figures in the field, and an Editorial Board of internationally diverse members suggests topics of special interest to their country/region and ensures that topics are current and include emerging research.